Kroger will sell Narcan nasal spray in its Dallas and Houston stores, without the need of a prescription.  Read More »

President Trump recently met with pharmaceutical executives concerning the prices of drugs and the regulations surrounding them. Read More »

In a letter sent to the U.S. House of Representatives, leaders from Americans for Tax Reform, Citizens Against Government Waste, and the National Taxpayers Union, urged congressional members to "oppose any attempts to change the successful and cost-saving process by which drug prices are negotiated for Medicare Part D." Read More »

Walgreens Boots Alliance and Rite Aid recently came to an agreement on a price reduction for the purchase of Rite Aid.  Read More »

Digital Pharmacist Inc. was launched Jan. 31 after the strategic merger of TeleManager Technologies Inc. and RxWiki Inc. Read More »

Sanofi has received FDA approval of Xyzal Allergy 24HR, an over-the-counter option for those suffering with certain allergies.  Read More »

Blue Shield of California and OptumRX will co-sponsor agricultural trade organization UnitedAg's 37th Annual Meeting and Conference in Napa, California, March 14-17. Read More »

Access to affordable and dependable health care for women has become  growing issue, and one facility says that it is prepared to play a big role in the solution in making women’s health care more accessible. Read More »

As the Trump Administration and new Congress signal their intent to somehow deal with the issue of rising prescription drug prices, the notion of giving the federal government more power to negotiate drug prices in Medicare Part D has been suggested as one measure that might be implemented. Two leading experts this week, however, threw cold water on that proposal, noting that such negotiations already exist and serve to bring down drug costs. Read More »

The U.S. Food and Drug Administration released its final guidance on naming biologics and biosimilars. Read More »

Systech International's Serialized by November program helped numerous manufacturers comply with the standards outlined in the Drug Supply Chain Security Act before its deadline. Read More »

ABBV-8E 12 -- a new Alzheimer’s treatment still in development -- received a fast-track designation from the U.S. Food and Drug Administration to be moved to clinical trials. Read More »

CTI BioPharma Corp., a company that specializes in developing blood cancer treatments, has named Michael Metzger its new director. Read More »

Relmada Therapeutics, a biopharmaceutical company that specializes in developing treatments for central nervous system diseases, received approval from the U.S. Food and Drug Administration to advance a new therapy to clinical trials. Read More »

The U.S. Food and Drug Administration has approved Linzess, a treatment for people suffering with chronic idiopathic constipation. Read More »

DePuy Synthes and Pacira Pharmaceuticals have entered into a partnership to promote pain reliever Exparel. Read More »

The U.S. Food and Drug Administration has given approval for the use of Narcan, an emergency treatment medication to counteract heroin overdoses, in a nasal spray form. Read More »

The rate of kidney failure related to diabetes among Native American adults dropped more than 50 percent between 1996 and 2013, the Centers for Disease Control and Prevention reported recently. Read More »

Johnson & Johnson has bought the controlling shares of Switzerland-based Actelion, with an immediate finalization of the transaction.  Read More »

A clear plurality (almost half) of American consumers blame drug makers for high drug costs, according to a new Google Consumer Survey conducted for American Pharmacy News. Read More »